SCHEMBL5138538

SCHEMBL5138538

CC1(c2nc(-c3cc4nc(-c5ccccc5)ccc4cc3Cl)c3cnccn23)CC(N2CCC2)C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 12/20 0.40
CYP3A4 P08684 8/20 0.38
INSR P06213 3/20 0.37
MAPK3 P27361 2/20 0.37
MAPK1 P28482 2/20 0.37
KDR P35968 2/20 0.37
RIPK2 O43353 1/20 0.37
ROCK2 O75116 1/20 0.37
LATS1 O95835 1/20 0.37
LCK P06239 1/20 0.37
LYN P07948 1/20 0.37
RET P07949 1/20 0.37
ABCB1 P08183 1/20 0.37
MET P08581 1/20 0.37
FGFR1 P11362 1/20 0.37
INSRR P14616 1/20 0.37
FECH P22830 1/20 0.37
MARK3 P27448 1/20 0.37
FLT4 P35916 1/20 0.37
MAP2K2 P36507 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5138539 0.76 IGF1R (0.58) IGF1RCYP3A4INSRMAPK3MAPK1
SCHEMBL5082145 0.71 IGF1R (0.39) IGF1RCYP3A4INSRMAPK3MAPK1
SCHEMBL5369589 0.66 IGF1R (0.52) IGF1RCYP3A4INSR
SCHEMBL402699 0.65 IGF1R (0.62) IGF1RCYP3A4INSRMAPK3MAPK1
SCHEMBL5138428 0.64 IGF1R (0.47) IGF1RCYP3A4INSRMAPK3MAPK1
SCHEMBL5367129 0.63 PLAUR (0.40) IGF1RCYP3A4MAOAMAOBKCNH2
SCHEMBL402423 0.63 IGF1R (0.79) IGF1RCYP3A4INSRMAPK3MAPK1
SCHEMBL401087 0.63 IGF1R (0.75) IGF1RCYP3A4INSRMAPK3MAPK1
SCHEMBL5137559 0.61 IGF1R (0.45) IGF1RCYP3A4INSRMAPK3MAPK1
SCHEMBL5138756 0.61 IGF1R (0.44) IGF1RCYP3A4INSRKDREGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1979002-A2 COMBINATION OF IGFR INHIBITOR AND ANTI-CANCER AGENT OSI Pharmaceuticals, Inc. (US) 2008-10-15 EP disclosed
WO-2007075554-A2 COMBINATION OF IGFR INHIBITOR AND ANTI-CANCER AGENT OSI PHARMACEUTICALS, INC. (US) 2007-07-05 WO disclosed